financetom
Business
financetom
/
Business
/
Masimo smartwatches infringe Apple design patents, US jury says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Masimo smartwatches infringe Apple design patents, US jury says
Nov 3, 2024 12:04 PM

Oct 25 (Reuters) - Apple ( AAPL ) convinced a federal

jury on Friday that health monitoring tech company Masimo's ( MASI )

smartwatches infringe two of its design patents.

The jury, in Delaware, agreed with Apple ( AAPL ) that Masimo's ( MASI ) W1

and Freedom watches and chargers willfully violated Apple's ( AAPL )

patent rights in smartwatch designs, awarding the tech giant

$250 in damages. Apple's ( AAPL ) attorneys told the court the "ultimate

purpose" of its lawsuit was to win an injunction against sales

of Masimo's ( MASI ) smartwatches after an infringement ruling.

The jury also determined that Masimo's ( MASI ) watches did not

infringe Apple ( AAPL ) patents covering smartwatch inventions that the

tech giant had accused Masimo ( MASI ) of copying.

Masimo ( MASI ) said in a statement that the company appreciated the

jury's verdict "in favor of Masimo ( MASI ) and against Apple ( AAPL ) on nearly

all issues," and that the decision only applied to a

"discontinued module and charger."

"Apple ( AAPL ) primarily sought an injunction against Masimo's ( MASI )

current products, and the jury's verdict is a victory for Masimo ( MASI )

on that issue," Masimo ( MASI ) said.

Apple ( AAPL ) said in a statement that it was "glad the jury's

decision today will protect the innovations we advance on behalf

of our customers."

Irvine, California-based Masimo ( MASI ) accused Apple ( AAPL ) of hiring

away its employees and stealing its pulse oximetry technology

after discussing a potential collaboration. Masimo ( MASI ) convinced the

U.S. International Trade Commission last year to block imports

of Apple's ( AAPL ) Series 9 and Ultra 2 smartwatches after the

commission found that their technology for reading blood oxygen

levels infringed Masimo's ( MASI ) patents.

Apple ( AAPL ) has appealed the decision and resumed selling the

watches after removing the technology. The tech giant

countersued Masimo ( MASI ) for patent infringement in 2022, alleging

that Masimo ( MASI ) copied Apple Watch features to use in its

smartwatches.

Apple ( AAPL ) also accused Masimo ( MASI ) of using lawsuits at the ITC

and in California to "make way for Masimo's ( MASI ) own watch." Masimo ( MASI )

said Apple's ( AAPL ) patent lawsuit was "retaliatory" and "an attempt to

avoid the court in which the parties have been litigating their

dispute."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Saudi Aramco returns to debt market with three-tranche dollar bond sale
Saudi Aramco returns to debt market with three-tranche dollar bond sale
Jul 8, 2024
July 9 (Reuters) - Energy giant Saudi Aramco made its return to the debt market on Tuesday after a three-year hiatus, mandating banks for 10-, 30- and 40-year senior unsecured tranche debt sales, a document from one of the lenders showed. The banks will arrange investor calls on Tuesday for the potential sale of benchmark-sized notes, according to the document,...
China's Guangzhou R&F Properties faces liquidation petition in Hong Kong
China's Guangzhou R&F Properties faces liquidation petition in Hong Kong
Jul 8, 2024
(Reuters) -Chinese property developer Guangzhou R&F Properties said on Tuesday its unit Trillion Glory had received a winding-up petition from a Singapore-based private equity fund due to non-repayment of a loan. The petition was filed on Monday at a Hong Kong Court by Seatown Private Credit Master Fund, which holds an 18% interest in the total outstanding loan amounting to...
Grifols says founding family, Brookfield looking to delist drugmaker
Grifols says founding family, Brookfield looking to delist drugmaker
Jul 8, 2024
LONDON/MADRID/BARCELONA, July 8 (Reuters) - The Grifols family and Canadian fund Brookfield have agreed to evaluate a possible joint takeover bid for beleaguered Spanish drugmaker Grifols with the intent to delist it, the companies said in regulatory filings on Monday. Grifols said its board held an extraordinary meeting over the weekend to study a preliminary offer presented by Brookfield and...
Shock French left election win is little solace for nervous investors
Shock French left election win is little solace for nervous investors
Jul 8, 2024
By Yoruk Bahceli and Samuel Indyk (Reuters) -A shock election win for France's leftist alliance has reinforced wariness among investors who had already braced for the risk of political deadlock and a policy paralysis that's unlikely to improve the country's creaking public finances. The left-wing New Popular Front (NFP) alliance won the most seats in Sunday's election, but fell far...
Copyright 2023-2026 - www.financetom.com All Rights Reserved